Bruker Corporation Acquires Remaining Stake in TOFWERK AG
January 8, 2026
Bruker Corporation acquired the remaining 60% ownership stake in TOFWERK AG, consolidating its ownership to 100%. The acquisition brings TOFWERK's compact, ultra-fast time-of-flight mass spectrometry technology and ~130 employees into Bruker's portfolio to expand capabilities and address applied markets such as air quality, semiconductor cleanroom monitoring, and food/flavors testing.
- Buyers
- Bruker Corporation
- Targets
- TOFWERK AG
- Industry
- Manufacturing
- Location
- Bern, Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires NanoString Technologies Business
May 6, 2024
Medical Devices
Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.
-
Bruker Corporation Acquires Tornado Spectral Systems Inc.
January 4, 2024
Medical Devices
Bruker Corporation has acquired Tornado Spectral Systems Inc., a Mississauga, Ontario-based maker of process Raman instruments, to expand Bruker’s biopharma Process Analytical Technology (PAT) product portfolio. Financial terms were not disclosed; Tornado’s HTVS-enabled Raman analyzers and probes will be integrated into Bruker’s spectroscopy and biopharma offerings to enhance process monitoring and quality control capabilities.
-
Bruker Corporation Acquires Prolab Instruments GmbH
January 19, 2022
Medical Devices
Bruker Corporation (Nasdaq: BRKR) has acquired Prolab Instruments GmbH, a Swiss developer of low-flow, high-precision UHPLC pumps, autosamplers and nano-/cap-LC systems, to strengthen its proteomics and metabolomics workflows. Financial terms were not disclosed; Bruker said the acquisition will accelerate product innovation and improve single-cell and high-sensitivity proteomics capabilities.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Bruker Corporation Acquires PepSep (nanoLC columns maker)
February 4, 2022
Medical Devices
Bruker Corporation acquired PepSep, a Danish maker of nanoflow liquid chromatography (nanoLC) columns, emitters and components to expand its timsTOF 4D‑Proteomics consumables portfolio. Financial terms were not disclosed; Bruker also announced an OEM agreement with IonOpticks to produce Bruker-branded high-performance pulled-tip columns.
-
Thermo Fisher Scientific Acquires Olink Holding AB
July 10, 2024
Biotechnology
Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.